163 related articles for article (PubMed ID: 31402912)
1. A Dual Inhibitor of Cdc7/Cdk9 Potently Suppresses T Cell Activation.
Chen EW; Tay NQ; Brzostek J; Gascoigne NRJ; Rybakin V
Front Immunol; 2019; 10():1718. PubMed ID: 31402912
[TBL] [Abstract][Full Text] [Related]
2. A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy.
McLaughlin RP; He J; van der Noord VE; Redel J; Foekens JA; Martens JWM; Smid M; Zhang Y; van de Water B
Breast Cancer Res; 2019 Jul; 21(1):77. PubMed ID: 31262335
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of action of a dual Cdc7/Cdk9 kinase inhibitor against quiescent and proliferating CLL cells.
Natoni A; Murillo LS; Kliszczak AE; Catherwood MA; Montagnoli A; Samali A; O'Dwyer M; Santocanale C
Mol Cancer Ther; 2011 Sep; 10(9):1624-34. PubMed ID: 21768328
[TBL] [Abstract][Full Text] [Related]
4. Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil.
Li W; Zhao XL; Shang SQ; Shen HQ; Chen X
Curr Cancer Drug Targets; 2015; 15(3):196-204. PubMed ID: 25643258
[TBL] [Abstract][Full Text] [Related]
5. Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML.
O' Reilly E; Dhami SPS; Baev DV; Ortutay C; Halpin-McCormick A; Morrell R; Santocanale C; Samali A; Quinn J; O'Dwyer ME; Szegezdi E
Sci Rep; 2018 Oct; 8(1):15752. PubMed ID: 30361682
[TBL] [Abstract][Full Text] [Related]
6. Targeting Inflammation, PHA-767491 Shows a Broad Spectrum in Protein Aggregation Diseases.
Chung YH; Lin CW; Huang HY; Chen SL; Huang HJ; Sun YC; Lee GC; Lee-Chen GJ; Chang YC; Hsieh-Li HM
J Mol Neurosci; 2020 Jul; 70(7):1140-1152. PubMed ID: 32170713
[TBL] [Abstract][Full Text] [Related]
7. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
[TBL] [Abstract][Full Text] [Related]
8. Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes.
Salerno D; Hasham MG; Marshall R; Garriga J; Tsygankov AY; Graña X
Gene; 2007 Dec; 405(1-2):65-78. PubMed ID: 17949927
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase C signaling during T cell activation induces the endoplasmic reticulum stress response.
Pino SC; O'Sullivan-Murphy B; Lidstone EA; Thornley TB; Jurczyk A; Urano F; Greiner DL; Mordes JP; Rossini AA; Bortell R
Cell Stress Chaperones; 2008 Dec; 13(4):421-34. PubMed ID: 18418732
[TBL] [Abstract][Full Text] [Related]
10. Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach.
Cheng AN; Lo YK; Lin YS; Tang TK; Hsu CH; Hsu JT; Lee AY
EBioMedicine; 2018 Oct; 36():241-251. PubMed ID: 30293817
[TBL] [Abstract][Full Text] [Related]
11. PDK1 nucleates T cell receptor-induced signaling complex for NF-kappaB activation.
Lee KY; D'Acquisto F; Hayden MS; Shim JH; Ghosh S
Science; 2005 Apr; 308(5718):114-8. PubMed ID: 15802604
[TBL] [Abstract][Full Text] [Related]
12. T cell activation up-regulates the expression of the focal adhesion kinase Pyk2: opposing roles for the activation of protein kinase C and the increase in intracellular Ca2+.
Tsuchida M; Manthei ER; Alam T; Knechtle SJ; Hamawy MM
J Immunol; 1999 Dec; 163(12):6640-50. PubMed ID: 10586059
[TBL] [Abstract][Full Text] [Related]
13. Vav cooperates with CD28 to induce NF-kappaB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1.
Marinari B; Costanzo A; Viola A; Michel F; Mangino G; Acuto O; Levrero M; Piccolella E; Tuosto L
Eur J Immunol; 2002 Feb; 32(2):447-56. PubMed ID: 11813163
[TBL] [Abstract][Full Text] [Related]
14. A Cdc7 kinase inhibitor restricts initiation of DNA replication and has antitumor activity.
Montagnoli A; Valsasina B; Croci V; Menichincheri M; Rainoldi S; Marchesi V; Tibolla M; Tenca P; Brotherton D; Albanese C; Patton V; Alzani R; Ciavolella A; Sola F; Molinari A; Volpi D; Avanzi N; Fiorentini F; Cattoni M; Healy S; Ballinari D; Pesenti E; Isacchi A; Moll J; Bensimon A; Vanotti E; Santocanale C
Nat Chem Biol; 2008 Jun; 4(6):357-65. PubMed ID: 18469809
[TBL] [Abstract][Full Text] [Related]
15. Bcl10/Malt1 signaling is essential for TCR-induced NF-kappaB activation in thymocytes but dispensable for positive or negative selection.
Jost PJ; Weiss S; Ferch U; Gross O; Mak TW; Peschel C; Ruland J
J Immunol; 2007 Jan; 178(2):953-60. PubMed ID: 17202357
[TBL] [Abstract][Full Text] [Related]
16. Activation of nuclear factor-kappaB via T cell receptor requires a Raf kinase and Ca2+ influx. Functional synergy between Raf and calcineurin.
Kanno T; Siebenlist U
J Immunol; 1996 Dec; 157(12):5277-83. PubMed ID: 8955173
[TBL] [Abstract][Full Text] [Related]
17. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems.
Kobayashi K; Inohara N; Hernandez LD; Galán JE; Núñez G; Janeway CA; Medzhitov R; Flavell RA
Nature; 2002 Mar; 416(6877):194-9. PubMed ID: 11894098
[TBL] [Abstract][Full Text] [Related]
18. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia.
Vacca A; Felli MP; Palermo R; Di Mario G; Calce A; Di Giovine M; Frati L; Gulino A; Screpanti I
EMBO J; 2006 Mar; 25(5):1000-8. PubMed ID: 16498412
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutagenesis studies of NF-kappa B signaling in human T cells: evidence for an essential role of IKK gamma in NF-kappa B activation by T-cell costimulatory signals and HTLV-I Tax protein.
Harhaj EW; Good L; Xiao G; Uhlik M; Cvijic ME; Rivera-Walsh I; Sun SC
Oncogene; 2000 Mar; 19(11):1448-56. PubMed ID: 10723136
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase Cγ1 is required for pre-TCR signal transduction and pre-T cell development.
Fu G; Yu M; Chen Y; Zheng Y; Zhu W; Newman DK; Wang D; Wen R
Eur J Immunol; 2017 Jan; 47(1):74-83. PubMed ID: 27759161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]